Chew Y P, Ellis M, Wilkie S, Mittnacht S
Institute of Cancer Research, Chester Beatty Laboratory, London, UK.
Oncogene. 1998 Oct 29;17(17):2177-86. doi: 10.1038/sj.onc.1202443.
Progression of cells into S phase is controlled by the retinoblastoma protein (pRB) and relies on the functional inactivation of this tumour suppressor in late G1 via protein phosphorylation. We provide evidence here that, besides controlling entry of cells into S phase, pRB can operate to inhibit S phase completion. Differential arrays of phosphorylation appear to regulate these different events, suggesting that cycle progression at these two stages of the cell cycle may be achieved via activation of distinct downstream pRB effector pathways. In agreement with this hypothesis, pRB's ability to prevent S phase entry, but not its ability to inhibit S phase completion, correlates with repression of E2F-regulated promoters. Furthermore, ectopic expression of E2F or the E2F-regulated cyclin E gene promote S phase entry in cells expressing phosphorylation-defective pRB but neither is sufficient to trigger completion of S phase. Our findings raise the possibility that pRB, in addition to its well-established role in controlling a checkpoint in late G1, could be involved in the control of a further checkpoint operating during S phase and that implementation of this checkpoint relies on an as yet unidentified pRB effector distinct from E2F.
细胞进入S期的进程由视网膜母细胞瘤蛋白(pRB)控制,并且依赖于该肿瘤抑制因子在G1晚期通过蛋白磷酸化实现功能失活。我们在此提供证据表明,除了控制细胞进入S期外,pRB还可发挥作用抑制S期的完成。不同的磷酸化模式似乎调控着这些不同的事件,这表明细胞周期这两个阶段的进程可能是通过激活不同的下游pRB效应器途径来实现的。与该假说一致,pRB阻止细胞进入S期的能力,而非其抑制S期完成的能力,与E2F调控启动子的抑制相关。此外,E2F或E2F调控的细胞周期蛋白E基因的异位表达促进表达磷酸化缺陷型pRB的细胞进入S期,但两者均不足以触发S期的完成。我们的研究结果提出了一种可能性,即pRB除了在控制G1晚期的一个检查点中已确立的作用外,可能还参与控制S期期间运行的另一个检查点,并且该检查点的实施依赖于一个尚未确定的不同于E2F的pRB效应器。